-
More than 100 bills have been introduced in 42 states this year to regulate these companies, which serve as conduits for drug manufacturers, health insurers and pharmacies.
-
The agency is to decide by Monday whether to greenlight Biogen’s drug aducanumab, despite a near-unanimous rejection of the product by an FDA advisory committee of outside experts in November.
-
The move comes just days before a U.S. rule was set to go into effect allowing for bulk importation of drugs from Canada. Trump promised it would lower costs and be a "game changer" for seniors.
-
Three groups argue that HHS Secretary Alex Azar is “punting” to the states the responsibility for demonstrating the imports will be safe and save costs.
-
Two nearly identical drug implants have very different prices. The one for kids has a list price of $37,300. For adults, it's $4,400. A dad fought for his daughter to be able to get the cheaper drug.
-
Infants' Tylenol is the same strength as Children's Tylenol. Turns out, the price difference has to do with packaging and safety features.
-
The Food and Drug Administration approved a new gene therapy for a rare but devastating genetic disorder. The drugmaker says the cost is worth it because it's a one-time treatment that saves lives.
-
Proposed changes to some Medicare prescription drug plans are causing concern among patients with serious health conditions.
-
A Senate panel Monday moved forward with a bill that could allow the state to lower costs by importing drugs from Canada for prisoners and Medicaid…
-
Conservative author and health policy expert Avik Roy has a plan for universal health care.The president of the Foundation for Research on Equal…